GPC3 and pancreatic neoplasm: Given the potential significance of the Yao study for GPC3 as a novel prognostic and predictive marker in pancreatic adenocarcinoma, we wanted to see if we could replicate their GPC3 results in pancreatic cancers in our Canadian patient population.